Primary Article

Ballard Partners: Lobbying for tobacco, pesticide, alcohol, and chemical interests at the highest levels of Trump’s Washington 

Firm comes under scrutiny as Democrats say they want to investigate corporate influence and the White House tightens lobbyist access

Brian Ballard

An analysis of federal lobbying disclosures by U.S. Right to Know found that Ballard Partners reported more than $38 million in estimated lobbying fees between January 2025 and September 2026 from 79 health-harming companies and industry groups.